State of Wisconsin Investment Board’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-21,463
Closed -$2.3M 2607
2023
Q1
$2.3M Buy
21,463
+8,865
+70% +$1.02M 0.01% 1257
2022
Q4
$1.39M Buy
12,598
+1,051
+9% +$68.2K ﹤0.01% 1408
2022
Q3
$681K Sell
11,547
-500
-4% -$22.9K ﹤0.01% 1796
2022
Q2
$340K Sell
12,047
-27,453
-70% -$796K ﹤0.01% 2265
2022
Q1
$1.49M Hold
39,500
﹤0.01% 1566
2021
Q4
$1.56M Buy
39,500
+24,800
+169% +$776K ﹤0.01% 1330
2021
Q3
$349K Hold
14,700
﹤0.01% 1826
2021
Q2
$361K Buy
+14,700
New +$328K ﹤0.01% 1809

Other funds holding RXDX

State of Wisconsin Investment Board's RXDX Position: Q2 2023 in Review

State of Wisconsin Investment Board sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 21,463 shares — an estimated $2.3M sold.

State of Wisconsin Investment Board first reported a position in RXDX in Q2 2021 and held it in 8 quarters. The position peaked at $2.3M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

  • State of Wisconsin Investment Board reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 21,463 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $2.3M.
  • State of Wisconsin Investment Board first reported a position in Prometheus Biosciences, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • State of Wisconsin Investment Board's Prometheus Biosciences, Inc. Common Stock position peaked at $2.3M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2023, filed 14 Aug 2023.